Previous 10 | Next 10 |
home / stock / biov:cc / biov:cc news
BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021 BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability Profile with BVX-1021 Canada NewsWire VANCOUVER, BC , Nov...
BIOVAXYS ANNOUNCES COMPLETED PRIVATE PLACEMENT AND DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , Nov. 10, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has completed...
VANCOUVER, BC / ACCESSWIRE / October 6, 2022 / The Power Play by The Market Herald has announced the release of new interviews with RDARS, Infinity Stone Ventures, BioVaxys Technology, and Sitka Gold discussing their latest news. The Power Play by The Market Herald provides investors with a...
BIOVAXYS ANNOUNCES DEBT SETTLEMENT Canada NewsWire VANCOUVER, BC , Oct. 6, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ( "BioVaxys" or the "Company") announces that it has agreed to settle an aggregate of $300,...
Palm Beach, FL – October 6, 2022 – FinancialNewsMedia.com News Commentary – The global Cervical Cancer Treatment market has been expanding for several years and is projected to continue at a growing CAGR. Cervical Cancer is a cancer arising from the cervix w...
BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps BioVaxys Executes Binding Term Sheet for the US Marketing & Distribution for Papilocare Gel and Oral Immunocaps Canada NewsWire Agreement Include...
VANCOUVER, BC / ACCESSWIRE / September 28, 2022 / The Power Play by The Market Herald has announced the release of a new interview with BioVaxys Technology discussing their latest news. The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know ab...
BioVaxys Further Expands Vaccines Intellectual Property Portfolio Canada NewsWire VANCOUVER, BC , Sept. 28, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announced today that in an action that...
BIOVAXYS CLOSES FINAL TRANCHE OF NON-BROKERED PRIVATE PLACEMENT Canada NewsWire VANCOUVER, BC , Sept. 19, 2022 /CNW/ -- BioVaxys Technology Corp. ( CSE: BIOV, FRA: 5LB, OTCQB: BVAXF) ( "BioVaxys" or the "Company") is pleased to announce that it has cl...
BioVaxys Announces New Chief Financial Officer Canada NewsWire VANCOUVER, BC , Sept. 8, 2022 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that Mr. Craig Loverock ha...
News, Short Squeeze, Breakout and More Instantly...
Biovaxys Technology Corp. Company Name:
BIOV:CC Stock Symbol:
CNQC Market:
Biovaxys Technology Corp. Website:
BioVaxys Technology Corp. Announces Failure to File Cease Trade Order PR Newswire VANCOUVER, BC , May 16, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the " Company ") announces that the Ontario Securities Commission (...
Toronto, Ontario--(Newsfile Corp. - Le 16 mai/May 2024) - Effective immediately, BioVaxys Technology Corp. is suspended pursuant to CSE Policy 3. The suspension is considered a Regulatory Halt as defined in National Instrument 23-101 Trading Rules. A cease trade order has been issued by the Ontar...
BioVaxys Technology Corp. Closes SECOND Tranche of Private Placement Canada NewsWire // THIS PRESS RELEASE IS NOT INTENDED FOR RELEASE OR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC , May 10, 2024 /CNW/ -- BioVaxys Technology Corp. (CSE: B...